| ○種別 (必須): | □ | 学術論文 (審査論文)
| [継承] |
| ○言語 (必須): | □ | 英語
| [継承] |
| ○招待 (推奨): |
| ○審査 (推奨): |
| ○カテゴリ (推奨): |
| ○共著種別 (推奨): |
| ○学究種別 (推奨): |
| ○組織 (推奨): |
| ○著者 (必須): | 1. | (英) Hosoda Kazuaki (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 2. | (英) Wang Ming-Fu (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 3. | (英) Liao Mei-Ling (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 4. | (英) Chuang Chin-Kuang (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 5. | (英) Iha Miyuki (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 6. | (英) Clevidence Beverly (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 7. | 山本 茂
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| ○題名 (必須): | □ | (英) Anti-hyperglycemic effect of oolong tea in type 2 diabetes mellitus (日)
| [継承] |
| ○副題 (任意): |
| ○要約 (任意): | □ | (英) To determine the efficacy of oolong tea for lowering plasma glucose in type 2 diabetic patients in Miaoli, Taiwan. A total of 20 free-living subjects who had type 2 diabetes and took hyperglycemic drugs as prescribed were enrolled in the present study. Subjects consumed oolong tea (1,500 ml) or water for 30 days each in a randomized crossover design. Tea was not consumed for 14 days prior to treatments. Relative to initial concentrations, oolong tea markedly lowered concentrations of plasma glucose (from 229 +/- 53.9 to 162.2 +/- 29.7 mg/dl, P < 0.001) and fructosamine (from 409.9 +/- 96.1 to 323.3 +/- 56.4 micromol/l, P < 0.01), whereas the water control group had not changed (208.7 +/- 61.0 vs. 232.3 +/- 63.1 mg/dl for glucose and from 368.4 +/- 85.0 to 340.0 +/- 76.1 micromol/l for fructosamine). Oolong tea may be an effective adjunct to oral hypoglycemic agents in the treatment of type 2 diabetes. (日)
| [継承] |
| ○キーワード (推奨): | 1. | (英) Age of Onset (日) (読)
| [継承] |
| 2. | (英) Biological Markers (日) (読)
| [継承] |
| 3. | (英) Blood Glucose (日) (読)
| [継承] |
| 4. | (英) Diabetes Mellitus, Type 2 (日) (読)
| [継承] |
| 5. | (英) Dietary Supplements (日) (読)
| [継承] |
| 6. | (英) Fructosamine (日) (読)
| [継承] |
| 7. | (英) Humans (日) (読)
| [継承] |
| 8. | (英) Hypoglycemic Agents (日) (読)
| [継承] |
| 9. | (英) Middle Aged (日) (読)
| [継承] |
| 10. | (英) Tea (日) (読)
| [継承] |
| 11. | (英) Treatment Outcome (日) (読)
| [継承] |
| ○発行所 (推奨): | □ | The American Diabetes Association
| [継承] |
| ○誌名 (必須): | □ | Diabetes Care ([The American Diabetes Association])
(pISSN: 0149-5992, eISSN: 1935-5548)
| ○ISSN (任意): | □ | 0149-5992
ISSN: 0149-5992
(pISSN: 0149-5992, eISSN: 1935-5548) Title: Diabetes careTitle(ISO): Diabetes CarePublisher: American Diabetes Association (NLM Catalog)
(Scopus)
(CrossRef)
(Scopus information is found. [need login]) | [継承] |
| [継承] |
| ○巻 (必須): | □ | 26
| [継承] |
| ○号 (必須): | □ | 6
| [継承] |
| ○頁 (必須): | □ | 1714 1718
| [継承] |
| ○都市 (任意): |
| ○年月日 (必須): | □ | 西暦 2003年 6月 初日 (平成 15年 6月 初日)
| [継承] |
| ○URL (任意): |
| ○DOI (任意): | □ | 10.2337/diacare.26.6.1714 (→Scopusで検索)
| [継承] |
| ○PMID (任意): | □ | 12766099 (→Scopusで検索)
| [継承] |
| ○CRID (任意): |
| ○WOS (任意): |
| ○Scopus (任意): |
| ○評価値 (任意): |
| ○被引用数 (任意): |
| ○指導教員 (推奨): |
| ○備考 (任意): | 1. | (英) Article.Affiliation: Research Center, Suntory, Osaka, Japan. (日)
| [継承] |
| 2. | (英) Article.PublicationTypeList.PublicationType: Clinical Trial (日)
| [継承] |
| 3. | (英) Article.PublicationTypeList.PublicationType: Comparative Study (日)
| [継承] |
| 4. | (英) Article.PublicationTypeList.PublicationType: Journal Article (日)
| [継承] |
| 5. | (英) Article.PublicationTypeList.PublicationType: Randomized Controlled Trial (日)
| [継承] |